Cml Biotech Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 03-11-2024
- Paid Up Capital ₹ 16.73 Cr
as on 03-11-2024
- Company Age 25 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 78.74 Cr
as on 03-11-2024
- Satisfied Charges ₹ 30.24 Cr
as on 03-11-2024
- Revenue -19.08%
(FY 2023)
- Profit -88.70%
(FY 2023)
- Ebitda -45.90%
(FY 2023)
- Net Worth 15.19%
(FY 2023)
- Total Assets 52.12%
(FY 2023)
About Cml Biotech
The Corporate was formerly known as Cml Biotech Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 16.73 Cr.
The company currently has active open charges totaling ₹78.74 Cr. The company has closed loans amounting to ₹30.24 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Cml Biotech Limited India is Sabu Jose as CFO. Poulose Chaku, Paul Shalini, Bhaskaranpillai Santoshkumar, and Five other members serve as directors at the Company.
- CIN/LLPIN
U51397KL1999PLC012944
- Company No.
012944
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Apr 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Cml Biotech Limited offer?
Cml Biotech Limited offers a wide range of products and services, including Blood Collection Tubes, Non Vacuum Blood Collection Tube, Vacuum Blood Collection Tube, Rapid Test Kit, Diagnostic Test Kit, Clot Activator Tube, Plastic & Glass Labware, Laboratory Plasticware, Paper & Paper Made Products, Paper Rolls.
Who are the key members and board of directors at Cml Biotech?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sabu Jose | CFO | 18-May-2024 | Current |
Mr Jacob  | Managing Director | 01-Mar-2006 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parapully Joshy | Director | 10-Jul-2018 | Current |
| Ashwin Paul | Director | 22-May-2021 | Current |
| Poulose Chaku | Director | 10-Jul-2018 | Current |
| Paul Shalini | Director | 22-May-2021 | Current |
| Bhaskaranpillai Santoshkumar | Director | 01-Jun-2023 | Current |
| Ajayaghosh Ayyappan | Director | 18-May-2024 | Current |
Financial Performance of Cml Biotech.
Cml Biotech Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.08% decrease. The company also saw a substantial fall in profitability, with a 88.7% decrease in profit. The company's net worth Soared by an impressive increase of 15.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cml Biotech?
In 2023, Cml Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Astra Bioscience LimitedActive 20 years 4 monthsPoulose Chaku, Parapully Joshy and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 30 Nov 2023 | ₹3.16 Cr | Open |
Sidbi Creation Date: 27 Nov 2023 | ₹2.00 Cr | Open |
Sidbi Creation Date: 19 Apr 2023 | ₹1.00 Cr | Open |
How Many Employees Work at Cml Biotech?
Cml Biotech has a workforce of 108 employees as of Nov 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cml Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cml Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
